Cargando…
Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy
BACKGROUND: Dendritic cell (DC)-based tumor vaccine is an attractive modality for the treatment of colon cancer because it has been recurred and produced few side effects in patients. Secretory glycoprotein 90K has been found at elevated level in various cancer tissues and sera. We investigated to e...
Autores principales: | Lee, Ji Hee, Park, Myung Suk, Chung, Ik Joo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026940/ https://www.ncbi.nlm.nih.gov/pubmed/21286381 http://dx.doi.org/10.4110/in.2010.10.6.206 |
Ejemplares similares
-
Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.
por: Vose, B. M., et al.
Publicado: (1981) -
Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004) -
The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins
Publicado: (1978) -
MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
por: Roulois, David, et al.
Publicado: (2013) -
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
por: Klement, John D., et al.
Publicado: (2021)